Kimura ET - Search Results

1

Autonomously functioning thyroid nodules are not associated with BRAF mutations.

Kimura ET, Vanvooren V, van Sande J, Nikiforov YE, Fagin JA. Kimura ET, et al. Clin Endocrinol (Oxf). 2004 Mar;60(3):394-6. doi: 10.1111/j.1365-2265.2004.01991.x. Clin Endocrinol (Oxf). 2004. PMID: 15009007 No abstract available.

2

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.

Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE. Nikiforova MN, et al. Among authors: kimura et. J Clin Endocrinol Metab. 2003 Nov;88(11):5399-404. doi: 10.1210/jc.2003-030838. J Clin Endocrinol Metab. 2003. PMID: 14602780

3

[Thyroid cancer: past, present and future].

Fagin JA, Ward LS, Kimura ET. Fagin JA, et al. Among authors: kimura et. Arq Bras Endocrinol Metabol. 2007 Jul;51(5):641-2. doi: 10.1590/s0004-27302007000500001. Arq Bras Endocrinol Metabol. 2007. PMID: 17891227 Portuguese. No abstract available.

4

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. Kimura ET, et al. Cancer Res. 2003 Apr 1;63(7):1454-7. Cancer Res. 2003. PMID: 12670889

5

Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKCepsilon in PCCL3 thyroid cells.

Knauf JA, Ouyang B, Croyle M, Kimura E, Fagin JA. Knauf JA, et al. Oncogene. 2003 Oct 9;22(44):6830-8. doi: 10.1038/sj.onc.1206829. Oncogene. 2003. PMID: 14534528

6

Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogene.

Chen X, Mitsutake N, LaPerle K, Akeno N, Zanzonico P, Longo VA, Mitsutake S, Kimura ET, Geiger H, Santos E, Wendel HG, Franco A, Knauf JA, Fagin JA. Chen X, et al. Among authors: kimura et. Proc Natl Acad Sci U S A. 2009 May 12;106(19):7979-84. doi: 10.1073/pnas.0900343106. Epub 2009 Apr 29. Proc Natl Acad Sci U S A. 2009. PMID: 19416908 Free PMC article.

7

Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis.

Oler G, Ebina KN, Michaluart P Jr, Kimura ET, Cerutti J. Oler G, et al. Among authors: kimura et. Clin Endocrinol (Oxf). 2005 Apr;62(4):509-11. doi: 10.1111/j.1365-2265.2005.02235.x. Clin Endocrinol (Oxf). 2005. PMID: 15807885 No abstract available.

8

Morphological and functional polymorphism within clonal thyroid nodules.

Aeschimann S, Kopp PA, Kimura ET, Zbaeren J, Tobler A, Fey MF, Studer H. Aeschimann S, et al. Among authors: kimura et. J Clin Endocrinol Metab. 1993 Sep;77(3):846-51. doi: 10.1210/jcem.77.3.8370709. J Clin Endocrinol Metab. 1993. PMID: 8370709

9

Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters.

Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF, Studer H. Kopp P, et al. Among authors: kimura et. J Clin Endocrinol Metab. 1994 Jul;79(1):134-9. doi: 10.1210/jcem.79.1.7517946. J Clin Endocrinol Metab. 1994. PMID: 7517946

10

Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.

Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET. Martins L, et al. Among authors: kimura et. J Clin Endocrinol Metab. 2002 Oct;87(10):4806-10. doi: 10.1210/jc.2002-020094. J Clin Endocrinol Metab. 2002. PMID: 12364477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page